Abstract
Melanoma accounts for only 4% of skin malignancies, but is considered the most serious one as it takes the patient to death in a few months. Because MAPK pathway is closely related to uncontrolled cell proliferation, especially in melanoma, this route has become a target for the development of oncogene targeted therapies. Such is the case of the potent chemotherapeutic drugs Vemurafenib (…